baber/WOPTO huggingface dataset:
Patent NZ-216550-A (NZ)
Title: Pyrrolidone derivatives and pharmaceutical compositions
Inventor: PINZA M
IPC: C07K5/06
Filed: 1986-06-16
Abstract: Compounds of Structure 1 
<CHEM>
 in which
 R<1> is hydrogen or C1-4 alkyl (straight or branched), and
 R<2> is hydrogen or C1-4 alkyl (straight or branched),
 processes and intermediates for making them, pharmaceutical compositions containing them, and their use as nootropic agents.
Patent NZ-216741-A (NZ)
Title: 6-oxo-1,6-dihydropyridazines and pharmaceutical compositions
Inventor: PRAIN H D
IPC: A61P9/00
Filed: 1986-07-03
Abstract: Compounds of the formula (I) : 
<CHEM>
and pharmaceutically acceptable salts are described wherein R<1> is hydrogen or methyl; R<2> is hydrogen or methyl; .... and ---- represent double or single bonds; and the benzene ring is para- or meta-substituted. These compounds have inotropic and vasodilator properties. Pharmaceutical compositions and methods of use are described.
Patent NZ-223154-A (NZ)
Title: Composition and method for producing superovulation in cattle comprising fsh and lh
Inventor: DONALDSON ERIC LLOYD
IPC: A61K38/00
Filed: 1988-01-11
Abstract: A hormone composition for producing superovulation in cattle. The composition has a particular ratio of follicle stimulating hormone (FSH) and luteinizing hormone (LH) which produces an optimum superovulation response in cattle. The composition can be produced from animal pituitary glands or by recombinant DNA procedures.
Patent NZ-223157-A (NZ)
Title: Panel anchor
Inventor: FRICKER SIEGFRIED
IPC: E04F13/08
Filed: 1988-01-12
Abstract: The invention is intended to provide a simple holding and supporting anchor (1) which can be manufactured as a mass-produced article and which can be used in both horizontal and vertical joints and can absorb high supporting forces in any installation position, whilst having small dimensions. 
<??>The supporting anchor (1) according to the invention is characterised in that its longitudinal portion is designed as a tubular section, the outer surface of which has unevennesses successive in the axial direction of the anchor (1), for example deformations (10) or extensions (10') projecting on the surface, or both. 
<??>The main sector of use is the fastening of such an anchor (1) to a mounting base, for example a concrete structure or a building, etc. consisting of masonry. 
<IMAGE>
Patent NZ-228563-A (NZ)
Title: Skin care composition comprising an oil phase containing a non-ionic surfactant and an aqueous phase containing a thickening agent; preparation thereof
Inventor: NAVIN MANOHAR GERIA
IPC: A61K8/00
Filed: 1989-03-31
Abstract: A long lasting, esthetically pleasing skin care moisturizing composition comprising   (1) an oil phase comprising oil from about 30% to about 80% and a non-ionic surface active agent having an HLB number of about 7 to about 12, wherein the non-ionic surface active agent is present in an amount of about 5% to about 9%; (2) an aqueous phase comprising an aqueous thickening agent from about 0.05% to about 5% and water from about 15% to about 65% wherein the oil phase is added to the aqueous phase to form an emulsion has been developed. The method of preparation of the composition and a method of treating skin with the composition are also disclosed. m
Patent NZ-232679-A (NZ)
Title: Aqueous fabric softener composition comprising gelatin/ polyanionic material microcapsules
Inventor: MICHAEL DANIEL WAYNE
IPC: C11D17/06
Filed: 1990-02-26
Abstract: Microcapsules which are prepared using coacervation processes and/or which have a complex structures in which there is a large central core of encapsulated material, preferably perfume, and the walls contain small wall inclusion particles of either the core material or some other material that can be activated to disrupt the wall are disclosed. The microcapsules that are prepared by coacervation and contain perfume are especially desirable for inclusion in fabric softener compositions that have a pH of about 7 or less and which contain cationic fabric softener. The encapsulated perfume preferably does not contain large amounts of relatively water-soluble ingredients. Such ingredients are added separately to the fabric softener compositions. Ingredients that have high and low volatilities as compared to, e.g., the desired perfume, can either be added to, or removed from, the perfume to achieve the desired volatility.
Patent NZ-248032-A (NZ)
Title: Producing mirrors by depositing onto hot glass a reflecting layer and at least two reflection-enhancing layers
Inventor: JENKINSON TIMOTHY
IPC: G02B1/14
Filed: 1993-06-30
Abstract: A method of producing mirrors comprising depositing onto a ribbon of hot glass (1) during the production process a coating comprising a reflecting layer (3) and at least two reflection enhancing layers (4,5) whereby the mirrors have a visible light reflection of at least 70%. There is also provided a mirror having such a coating. In a preferred embodiment the coating comprises: an inner layer (3) having a refractive index of at least 1.6; an intermediate layer (4) of relatively low refractive index and; an outer layer (5) having a refractive index of at least 1.6; the intermediate layer (4) having a refractive index less than the refractive index of either said inner layer (3) or said outer layer (5) and less than 3, provided that at least one of said inner and outer layers (3,5) is of silicon, the aggregate refractive index of the inner and outer layers (3,5) is at least 5.5, and the thicknesses of the layers are such that the mirror has a visible light reflection of at least 70%. In an alternative embodiment, one of the inner and outer layers (3,5) may instead be composed of a low refractive index reflective metal. <IMAGE>
Patent NZ-250140-A (NZ)
Title: Beverage container with secondary chamber and tube ejecting gas and/or beverage for frothing in headspace when container opened
Inventor: LYNCH FRANCIS JOSEPH
IPC: B65D25/02
Filed: 1993-11-04
Abstract: A beverage package and a method of forming such a package has a can (1) within a primary chamber (5) of which is located an insert (6) having a secondary chamber (10). The insert has a seating in the form of a bore (11) within which is received the lower end of a tube (15). The tube (15) is fitted to the insert whilst the latter is positioned in the can. When the can is charged with beverage such as beer (20) having gas in solution and sealed to form a headspace (21) containing gas at a pressure greater than atmospheric, beer from the chamber (20) may fill the tube (15). The secondary chamber (10) contains gas at a pressure greater than atmospheric and on opening the container the headspace (21) de-pressurises causing beverage and/or gas from the secondary chamber to be ejected through the tube (15) and such ejection causes froth to be developed in the headspace (21). The tube (15) isolates a major part of the beer in the container from having its gas liberated so that such gas can evolve gradually to provide sparkle in the beer when the latter is poured into a glass. The tube is preferably press fitted into the socket (11). In an alternative arrangement the tube may be received on a spigot extending from the insert (6). Preferably the seating (11) is co-axial with a cylindrical can (1) and the tube (15) is curved to locate its upper end adjacent to the side wall (3) of the can. <IMAGE>
Patent NZ-253998-A (NZ)
Title: Floor matting for animal enclosure: laminate of puncture proof layer and resilient layer, with drainage apertures and channels
Inventor: BRODIE SCOTT
IPC: A01K1/015
Filed: 1993-07-22
Abstract: PCT No. PCT/AU93/00370 Sec. 371 Date Jan. 20, 1995 Sec. 102(e) Date Jan. 20, 1995 PCT Filed Jul. 22, 1993 PCT Pub. No. WO94/02003 PCT Pub. Date Feb. 3, 1994A floor/wall matting suitable for but not limited to animal stables, stalls, floats, etc. The floor/wall matting comprises a compressible support layer covered with an upper cover layer of puncture resistant moisture impervious material. The matting is formed with a plurality of apertures sized to allow passage of animal waste or debris from the upper surface of the matting to a plurality of drainage channels extending along an underside of the matting. The matting provides excellent physical and thermal insulation and hygienic conditions. The inventive floor/wall matting may be used in conjunction with a flushing system positioned adjacent the drainage channels to flush waste and debris which has passed through the apertures of the matting out of the drainage channels to a septic or sewerage outlet.
Patent NZ-260556-A (NZ)
Title: Aqueous machining fluid comprising an ester of a dialkyldithiocarbamic acid, a sulphurised hydrocarbon, and a sulphurised carboxylic acid or ester
Inventor: KRUEGER MARK K
IPC: C10N40/20
Filed: 1994-05-19
Abstract: An aq. machining fluid (I) comprises (a) water; (b) a sulphurised organic material selected from (i) sulphurised 6-22C unsatd. aliphatic carboxylic acids and salts thereof; (ii) sulphurised unsatd. esters of 1-22C aliphatic carboxylic acids; and (iii) sulphurised polymerised unsatd. fatty acids, and salts and esters thereof; (c) a sulphurised hydrocarbon; and (d) an aliphatic ester of a dialkyldithiocarbamic acid.
Patent NZ-261374-A (NZ)
Title: N-branched alkylbenzothiazolin-3-ones and use as microbiocides in paints
Inventor: AUSTIN PETER WILLIAM
IPC: C07D275/04
Filed: 1994-02-17
Abstract: PCT No. PCT/GB94/00320 Sec. 371 Date Aug. 9, 1995 Sec. 102(e) Date Aug. 9, 1995 PCT Filed Feb. 17, 1994 PCT Pub. No. WO94/20479 PCT Pub. Date Sep. 15, 1994The invention relates to N-( beta -branched alkyl)-1,2-benzisothiazolin-3-ones having two or more carbon atoms in the alkyl side chain such as N-(2-ethylhexyl)-1,2-benzisothiazolin-3-one, which are suitable as paint film fungicides.
Patent NZ-262349-A (NZ)
Title: Chemically modifying haemoglobin by crosslinking with a polyaldehyde produced by ring opening oxidation of a saccharide; for use in a blood substitute
Inventor: PLIURA DIANA H
IPC: A61P7/08
Filed: 1994-03-11
Abstract: Hemoglobin for forming the basis of blood substitute is modified by crosslinking it by reaction with a polyaldehyde produced by ring opening oxidation of a di/tri-saccharide such as raffinose, wherein the o-saccharide solutions are maintained and the reaction is conducted at a pH from about 5.0-7.0, and at a stoichiometry from about 1:1-4:1 based upon the molar ratio of di/tri-saccharide to hemoglobin tetramers, followed by appropriate reduction of the Schiff base linkages so formed to stabilize them. Careful control of the pH of ring opening of the di/tri-saccharide ensures consistent production of the polyaldehyde without unwanted side products and reaction of this product with the hemoglobin at the specified stoichiometry leads to high yields of stabilized, tetrameric hemoglobin and oligomers thereof of predetermined composition and beneficial properties.
Patent NZ-303260-A (NZ)
Title: Pharmaceutical composition containing selected lanthanum carbonate hydrates
Inventor: MURRER BARRY ANTHONY
IPC: C01F17/00
Filed: 1996-03-19
Abstract: elected lanthanum carbonate hydrates are said to be administrable into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.  The lanthanides are of the formula La2(CO3)3.xH2O where x is 3, 4, 5 or 6.
Patent NZ-331221-A (NZ)
Title: Novel piperidines derived from 1-/(piperazin-1-yl)aryl-(oxo/amino)carbonyl/-4-aryl-piperidine as selective 5-ht 1dbeta receptor antagonists
Inventor: HALAZY SERGE
IPC: A61P25/18
Filed: 1997-01-31
Abstract: he present invention relates to piperidines derived from arylpiperazine used as selective 5-HT1D›  antagonists. These have the formula 1 which: Ar1 is phenyl, or naphthyl which may be substituted from one of the groups: -	linear or branched alkyl residue comprising 1-6 carbon atoms -	trifluoromethyl -	ether (OR'2), -	thioether (SR'2) -	halogen -	amine -	nitro -	nitrile A-B represents CH-CH2 or C=CH, X is O, NO, Ch2O or CH2-NH  Ar2 represents a phenyl or a naphthyl to which X and piperazine are attached to different carbons and which may itself be variously substituted with a linear or branched alkyl radical comprising 1-6 carbon atoms, an ether or halogen.  R1, R2, R3 and R4 which are identical or different, represent a hydrogen, linear or branched alkyl chain comprising 1-6 carbon atoms, R'2 is linear or branched alkyl chain comprising 1-6 carbon atoms and their salts, hydrates, solvates and bioprecursors which are physiologically acceptable for therapeutic use. Also claimed is the process for making these compounds, and pharmaceutical composition comprising these compounds.
Patent NZ-334448-A (NZ)
Title: olanzapine dihydrate which can be used in a process for preparing olanzapine
Inventor: BUNNELL CHARLES A
IPC: A61K31/55
Filed: 1997-09-18
Abstract: The compound olanzapine dihydrate - "2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine dihydrate" is disclosed which is used in a method of producing a pure form of olanzapine form II. Also disclosed is a crystalline olanzapine dihydrate polymorph. The dihydrate is useful in treating psychotic disorders.
Patent NZ-500579-A (NZ)
Title: Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses
Inventor: BARABAS MIHALY
IPC: A01N43/88
Filed: 1998-04-21
Abstract: The use of hydroxylamine derivative compounds of formula (I) wherein: R1 represents phenyl, N-heteroaryl, S-heteroaryl or a naphthyl group which may be substituted with one or more halo, alkyl, alkoxy, haloalkyl or nitro, an unsubstituted or substituted phenylamino or alkylamino or lower alkyl; X represents halo, amino or an unsubstituted or substituted phenylamino group, or amino substituted with one or two lower alkyl or a hydroxy group provided that if R1 is unsubstituted or substituted phenylamino, alkylamino or lower alkoxy, then X may not be a halo; Y represents hydrogen, hydroxy or acyloxy, or longer alkanoyloxy, or if Y represents hydroxy, the molecule may contain a dioxazine ring closed at the carbon atom carrying the X group formed by formal XH elimination; R2 and R3, independently represent hydrogen or lower alkyl group provided that R2 and R3 may not be hydrogen simultaneously; R2 and R3 along with the adjacent nitrogen atom form a 5- to 7-membered saturated hetero ring; to increase the tolerance of cultivated plants against weather condition stresses, such as cold, frost and drought.
Patent NZ-501625-A (NZ)
Title: Milk derived calcium and magnesium precipitate and process for recovering the precipitate by cation-exchange resin
Inventor: TOBA YASUHIRO
IPC: B01D61/44
Filed: 1999-12-07
Abstract: A milk derived or milk substance magnesium/calcium material in which: -magnesium and calcium content is more than 13 % by weight of the total solids, and -magnesium and calcium salts have no distinct crystalline structure. Also described is a method for producing the above magnesium/calcium material from milk or milk substances wherein milk or milk substances are passed through weakly acidic cation-exchange resins, then strongly acidic cation-exchange resins, after which magnesium and calcium being absorbed onto the strongly acidic cation-exchange resins are eluted and recovered as magnesium and calcium salts, and wherein the volume ratio of the weakly acidic cation-exchange resins to the strongly acidic cation-exchange resins is such that the ratio by weight of magnesium to calcium recovered from elute is higher than in the milk or milk substances.
Patent NZ-504663-A (NZ)
Title: Self-service eye glasses / spectacles magnification test apparatus and display stand
Inventor: GASPER CARLISLE CHARLES FREDER
IPC: A47F7/02
Filed: 1998-11-19
Abstract: The apparatus includes a plurality of frames (13 - 13e) for eyeglass lenses, a plurality of pairs of lenses of different magnification secured within the frames, a support means (11, 12) holding the frames for a user of the apparatus to position their face so as to bring each of the frames in turn into a conventional eyeglass-wearing position, and a motif (36) of a predetermined size spaced at a predetermined distance from each frame being supported.
Patent NZ-507054-A (NZ)
Title: Purification of carboxaldehyde
Inventor: BERGLUND RICHARD ALAN
IPC: C07C45/85
Filed: 1999-03-15
Abstract: Described is a process for preparing and purifying 4'-chloro-4-biphenylcarboxaldehyde which comprises: (1)  reacting 4'-chloro-4-biphenylcarboxaldehyde with sodium bisulphite in an aqueous/acetonitrile solution having an acetonitrile concentration sufficient to cause the bisulphite adduct to precipitate. (2)  isolating the bisulphite adduct precipitate from the solution. (3)  mixing the isolated bisulphite adduct in an aqueous/acetonitrile solution having a water concentration sufficient to cause a regenerated aldehyde to precipitate. (4)  converting the bisulphite adduct to 4'-chloro-4-biphenylcarboxaldehyde.
Patent NZ-510003-A (NZ)
Title: Aryl or heteroaryl quinolinylphosphonic acid compounds
Inventor: CORDI ALEX
IPC: C07F9/60
Filed: 2001-02-16
Abstract: Compounds of formula I having powerful non-NMDA antagonist properties are described.  Specifically, compounds of formula I wherein: ·R1 represents a halogen atom or a trifluoromethyl group, ·R2 represents an aryl or heteroaryl group, ·R3 and R4, which may be identical or different, represent a hydrogen atom or an alkyl, cycloalkyl, aryl or arylalkyl group or the group -R5CH-O-CO-R6- (wherein R5 and R6, which may be identical or different, represent a hydrogen atom or an alkyl, cycloalkyl or aryl group). The process for the preparation of compounds of formula I from a starting material of formula II wherein R1 is as defined as for formula I is also described. The compounds are powerful therapeutic agents for the treatment of acute and chronic neurological and psychological disorders, for example degenerative disorders such as cerebrovascular accident, cerebral or spinal traumatism, epilepsy and chronic neurodegenerative diseases such as Alzheimer's disease, schizophrenia, lateral amyotrophic sclerosis or Huntington's chorea.
Patent NZ-515772-A (NZ)
Title: Pesticidal emulsion composition containing levamisole in the aqueous phase and an anthelmintic in the organic phase
Inventor: SORENSEN ALLEN PAUL
IPC: A01N43/90
Filed: 1999-06-04
Abstract: A storage stable veterinary composition contains at least one macrocyclic lactone, levamisole and at least one benzimidazole. The macrocyclic lactone is or includes invermectin and/or abamectin and the benzimidazole is or includes albendazole and/or oxafenazole.  The levamisole content is more than that of the total benzimidazole, which is more than the total macrocyclic lactone content. The different liquid carrier phases partition the invermectin and/or abamectin from the levamisole.  The albendazole and/or oxafenazole is particulate and is at least in part in an aqueous phase with the levamisole.  The aqueous phase is buffered to a pH appropriate for levamisole and its stability.  The invermectin and/or abamectin is in the organic phase.
Patent NZ-515861-A (NZ)
Title: Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
Inventor: PELLERIN CHARLES
IPC: C12Q1/6897
Filed: 2000-05-01
Abstract: The application concerns the development of a cell-based assay system having improved sensitivity to HCV NS3 protease activity, which is useful for screening test compounds capable of modulating (particularly inhibiting) HCV NS3 protease activity. This system provides a first construct comprising a transactivator domain joined downstream of the NS3-5 domains of HCV under the control of a non-cytopathic viral promoter system. A second construct is also provided that comprises a reporter gene under the control of an operator sensitive to the binding of the transactivator. The NS3-5 domains encodes the NS3 polyprotein which comprises: the NS3 protease, followed by the NS4A co-factor, the NS4B and NS5A proteins (including any derivative, variant or fragment thereof), terminated by the NS5B protein (including any derivative, variant or fragment thereof) sufficient to constitute a NS5A/5B cleavage site. The transactivator, when expressed and released from the polyprotein initiates transcription and expression of the reporter gene that is measurable.
Patent NZ-516790-A (NZ)
Title: Oral treatment of companion animals with ectoparasiticidal spinosyns
Inventor: SNYDER DANIEL EARL
IPC: C07H17/08
Filed: 2000-08-02
Abstract: Single-dose  oral  formulations  for  controlling   an ectoparasite  infestation  on  a  companion  animal  for   a prolonged  time,  said  formulations comprising  a  spinosyn component,  or  a physiologically acceptable  derivative  or salt  thereof,  and  a  carrier in oral  dosage  form.  Also provided  are  methods  for  controlling  such  infestations comprising  orally  administering a  single  dose  of  these formulations to the animal.
Patent NZ-519235-A (NZ)
Title: Method of flushing blood from the circulatory system of a dead fish
Inventor: GOULD TREVOR JAMES
IPC: A22C25/14
Filed: 2002-05-28
Abstract: A method and apparatus for removing blood from a dead fish especially salmon, consisting of killing and decapitating the fish before flushing the blood from the body with water. After the fish has been decapitated a hollow needle can be inserted into a vein or artery. Pressurised water is then supplied to the needle, which causes blood and other contaminants to be flushed from the fish's circulatory system. The removal of blood from the flesh of the fish is important in fish smoking processes as blood leads to dark blemishes on the finished product.
Patent NZ-521272-A (NZ)
Title: Storage and delivery of micro-organisms
Inventor: MCGRATH SUSAN
IPC: A23K1/00
Filed: 2001-03-12
Abstract: A method of delivering a micro-organism to an animal, the method comprising: (a) providing a formulation comprising a micro-organism, such as Lactobacillus or Enterococcus, suspended in or on a matrix; (b) providing a feed stream for the animal; (c) detaching the micro-organism from the matrix; and (d) entraining detached micro-organisms into the feed stream; and an apparatus for carrying out the method.
Patent NZ-522621-A (NZ)
Title: A street furniture structure having a display and closed circuit television security system
Inventor: MURPHY DAVID BARRY
IPC: G09F15/00
Filed: 2001-05-02
Abstract: A piece of street furniture comprising a structure having a display or advertising unit (7) and a multi- channel closed circuit television security system. The system includes video cameras (CAM1....CAMN) located in a camera housing (4) above the display unit (7), and connected to two or more video tape recorders (VCR1.....VCRN) located in a base storage unit (10) below the display unit (7). The video recorders (VCR) are interconnected, and connected to the outputs of the cameras (CAM), by circuitry associated with switching means (14) which is operable, when one recorder is recording the camera outputs and reaches a predetermined capacity, to cause the other recorder to commence recording the camera outputs, and vice versa. The camera outputs are therefore recorded by the recorders in turn, in a continuous loop.
Patent NZ-526139-A (NZ)
Inventor: VAN DER KLAAUW GUIDO PETRUS JO
IPC: B67D1/08
Filed: 2001-11-21
Abstract: A tapping rod (2) with a beverage valve (16), a gas valve (14) cooperating therewith, and a collar (24), while in or on the collar a connecting device (26) is fitted, which connecting device comprises a pressure body (30) for opening the beverage valve (16) and the gas valve (14), wherein: the pressure body (30) comprise or defines at least one first beverage channel for bringing, with the beverage valve in open position, the inner space of a keg, in particular a riser of the taping rod, into fluid communication with a beverage dispensing line; the pressure body comprises or defines at least one gas channel for bringing, with the gas valve in open position, the inner space of the keg into fluid communication with a gas supply line.